Christopher Nevala-Plagemann

8PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 17, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

|Feb 26, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.

Manish A Shah, Erin B Kennedy, Dana Deighton

|Jun 02, 2023
Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.

Vaia Florou, Andrew Elliott, Matthew H Bailey

|Sep 23, 2021
Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma.

Siddharth Iyengar, Christopher Nevala-Plagemann, Ignacio Garrido-Laguna

|Nov 10, 2019
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer.

Christopher Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido-Laguna

|Aug 20, 2019
Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab.

Christopher Nevala-Plagemann, Justin Moser, Glynn Weldon Gilcrease

Pageof 2

Frequent Collaborators

2 joint publications

Minaxi Jhawer

2 joint publications

Anwaar Saeed

2 joint publications

Kunal C Kadakia

2 joint publications

Kohei Shitara